Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Novavax Inc (NVAX) vs Advanced Drainage Systems Inc (WMS) Price & Performance

Novavax IncTrade
Advanced Drainage Systems IncTrade

Price performance (Past 24H)

Key statistics

Novavax Inc vs Advanced Drainage Systems Inc — how do they compare? Novavax Inc trades at $11.1 (market cap $1.82B), while Advanced Drainage Systems Inc trades at $127.14 (market cap $9.52B). The key difference: Advanced Drainage Systems Inc is far larger — about 5.2× Novavax Inc's market cap, and Advanced Drainage Systems Inc pays a 0.63% dividend while Novavax Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Novavax Inc for 59 Days and Advanced Drainage Systems Inc for 43 Days on average.

NVAXWMS
Market Cap
$1.82B$9.52B
Volume
6,198,505907,564
Sector
HealthBasic Materials
52-Week High
$12.56$175.38
52-Week Low
$6.22$125.33
Typical Hold Time
59 Days43 Days
Enterprise Value
$1.39B$11.12B
Dividend Yield
—0.63%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Novavax Inc

Novavax (NVAX) trades at $11.22, down 0.88% on the day, with a bullish technical signal from moving averages and strong analyst support (74% buy ratings). The company shows mixed fundamentals with a positive P/E of 3.14 and EV/EBITDA of 1.72, but negative net income margin of -59.87% and negative shareholder equity. Recent developments include regulatory approvals for its updated COVID-19 vaccine and strategic pivot toward Matrix-M adjuvant licensing partnerships.

The outlook remains speculative with significant execution risks in the transition from COVID vaccine dependency to partnership-driven model. While valuation metrics appear attractive and technical momentum is positive, persistent negative cash flows and competitive pressures in the biotech sector warrant caution. The stock presents high-risk, high-reward potential for investors comfortable with biotech volatility.

Advanced Drainage Systems Inc

Advanced Drainage Systems (WMS) trades at $126.08, down 3.07% on the day, amid a bearish technical signal. The stock has consistently beaten earnings estimates in recent quarters, with Q2 2026 EPS of $2.49 exceeding expectations. Revenue for 2025 was $2.90 billion, with a net income margin of 15.5%. The company maintains strong profitability metrics, including a 24.9% ROE, and recently announced a quarterly dividend. Analyst consensus is mixed with a $188.70 price target, while institutional activity shows both new acquisitions and reductions in holdings.

WMS presents a balanced outlook with solid fundamentals and recent earnings beats offset by near-term technical weakness. Investment opportunities include sustained revenue growth and margin expansion from operational efficiencies. Key risks involve competitive pressures in the construction sector and potential volatility from macroeconomic factors. The stock's current valuation at a P/E of 21.48 offers a reasonable entry point relative to growth prospects, but investors should monitor cash flow trends given the projected net cash outflow in 2026.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NVAX
59% Buy41% Sell
Avg holding period · 59 Days
WMS
100% Buy0% Sell
Avg holding period · 43 Days

Top news

Latest headlines on both assets

About Novavax Inc

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.

Read more on NVAX →

About Advanced Drainage Systems Inc

Advanced Drainage Systems Inc is engaged in designing, manufacturing, and marketing thermoplastic corrugated pipe and related water management products in North and South America, and Europe. The company's operating segment includes Pipe

Read more on WMS →